Evaluation of the Specialized Clinic for Nutrition and Mental Health: A Pilot Study
NCT07050342 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2025-07-03
Summary
The goal of this observational pilot study is to learn how personalized nutrition-focused care can help people with mental and psychosomatic health problems. This study takes place in Europe's first outpatient clinic that focuses on how diet affects mental well-being.
The main questions the study aims to answer are:
Does care at this clinic help lower participants' stress levels over one year?
Do participants report better mental health, resilience, and quality of life during the study?
Are improvements in mental health linked to changes in diet and blood markers like inflammation?
Participants will:
Fill out online questionnaires every 3 months over one year. These ask about stress, physical symptoms, quality of life, diet, and satisfaction with care.
Give small blood samples during their regular clinic visits. These samples will be checked for common health markers such as inflammation.
This study will help researchers understand whether nutrition-focused care can support mental and physical health, and whether this approach should be tested in larger future studies.
Conditions
- Psychosomatic Disorders
- Mental Health Care
Interventions
- OTHER
-
Personalized Nutrition-Based Psychosomatic Care
This intervention involves personalized, nutrition-focused care provided in a specialized outpatient clinic for individuals with psychosomatic and mental health conditions. The care model integrates nutritional counseling, education on gut-brain interactions, and patient-centered support to promote psychological well-being and reduce stress. No experimental drugs or diets are administered. Instead, the intervention focuses on individualized recommendations based on clinical assessments and ongoing routine laboratory markers (e.g., inflammatory markers, vitamin levels). Participants also receive guidance aimed at improving dietary habits and resilience within a biopsychosocial framework. The intervention is part of regular clinical care and not blinded or randomized.
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2028-06-01
- Completion
- 2028-12-01
Countries
- Austria
Study Locations
More Related Trials
-
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
NCT04366011 ·Status: COMPLETED ·Phase: NA
-
Study Of Generalized Anxiety Disorder
NCT00135525 ·Status: COMPLETED ·Phase: PHASE2
-
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
NCT01953042 ·Status: WITHDRAWN ·Phase: NA
-
Examining the Effects of Reduced Environmental Stimulation on Anxiety
NCT03051074 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Treatment for Generalized Anxiety Disorder
NCT00456742 ·Status: COMPLETED
-
Reducing Anxiety and Stress in Primary Care Patients
NCT03794089 ·Status: COMPLETED ·Phase: NA
-
Exercise Training for the Treatment of Generalized Anxiety Disorder
NCT00953654 ·Status: COMPLETED ·Phase: NA
-
Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
NCT02153944 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety
NCT03457922 ·Status: COMPLETED
-
Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis
NCT01119469 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-Response Safety Study of ENX-102 in Patients With GAD
NCT06653296 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
NCT00537615 ·Status: COMPLETED ·Phase: PHASE1
-
Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects
NCT01703832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder
NCT01949753 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized Controlled Trial of an Exposure-Based Treatment for Perfectionism
NCT05351710 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hypochondriasis With CBT and/or SSRI
NCT00339079 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Psychotherapy Outcome and Self-selection Effects in Panic Disorder
NCT01606592 ·Status: COMPLETED ·Phase: NA
-
Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting
NCT01081249 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy
NCT07052812 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
NCT04478526 ·Status: COMPLETED ·Phase: NA
-
Treating Emotional Disorders in Primary Care With Psychological Techniques
NCT01903096 ·Status: COMPLETED ·Phase: PHASE4
-
A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder
NCT07206212 ·Status: RECRUITING ·Phase: NA
-
Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
NCT02384369 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluate the Beneficial Effects of an Oral Nutritional Supplement Based on Leonurus Cardiaca for the Improvement of Mood and Anxiety
NCT06954038 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Psychological Mobile Interventions to Reduce Distress
NCT05294809 ·Status: COMPLETED ·Phase: NA